{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "INNO-GENE SA  ZY -,10", "longName": "Inno-Gene S.A.", "messageBoardId": "finmb_118031840", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -3.9525654, "regularMarketPrice": 1.215, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.72770053, "fiftyTwoWeekLow": 1.02, "fiftyTwoWeekHigh": 4.462, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.0, "sharesOutstanding": 5701080, "fiftyDayAverage": 1.11896, "fiftyDayAverageChange": 0.09604001, "fiftyDayAverageChangePercent": 0.085829705, "twoHundredDayAverage": 2.50485, "twoHundredDayAverageChange": -1.2898499, "twoHundredDayAverageChangePercent": -0.514941, "marketCap": 7053014, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": -0.049999952, "regularMarketTime": 1683875702, "regularMarketDayHigh": 1.215, "regularMarketDayRange": "1.215 - 1.215", "regularMarketDayLow": 1.215, "regularMarketPreviousClose": 1.265, "bid": 1.185, "ask": 1.295, "fullExchangeName": "Frankfurt", "financialCurrency": "PLN", "regularMarketOpen": 1.215, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.19500005, "fiftyTwoWeekLowChangePercent": 0.19117652, "fiftyTwoWeekRange": "1.02 - 4.462", "fiftyTwoWeekHighChange": -3.2469997, "firstTradeDateMilliseconds": 1620367200000, "symbol": "WQ3.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "ul. Sciegiennego 20", "city": "Poznan", "zip": "60-128", "country": "Poland", "phone": "48 509 65 80 06", "fax": "48 616 23 25 26", "website": "https://www.inno-gene.pl", "industry": "Diagnostics & Research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "longBusinessSummary": "Inno-Gene S.A. provides genetic diagnostic solutions in Poland. It is involved in the research and diagnostic center implementation; and the provision of technologies in the field of DNA analysis. The company also develops and implements diagnostic algorithm for prevention and personalization of treatment of HPV-dependent solid tumors. In addition, it provides DNA analysis and genetic diseases diagnostic service based on NGS technology. Inno-Gene S.A. was incorporated in 2010 and is headquartered in Poznan, Poland.", "fullTimeEmployees": 11, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jacek Marek Wojciechowicz", "title": "Pres of the Management Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Rafal  Gebicki", "title": "Financial Director & Member of Management Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}